Skip to main content
. 2021 Apr 5;2021:6665601. doi: 10.1155/2021/6665601

Figure 11.

Figure 11

Schematic diagram showing the immunomodulatory effect of BM-MSCs+IMC administered concurrently in CFA-induced arthritis. IMC: indomethacin; BM-MSCs: bone marrow-derived mesenchymal stem cells; Th2: T helper 2; DC: dendritic cell; IL-10: interleukin 10; T cell: T lymphocytes; B cell: B lymphocytes; Mono: monocytes; Neut: neutrophils; SM: synovial membrane; iNOS: inducible nitric oxide synthase; TGF-β1: transforming growth factor-beta-1; TNF-α: tumor necrosis factor-alpha; anti-CCP: anticyclic citrullinated peptide antibody; MMP-9: matrix metalloproteinase-9.